US Patent 8158653 Pharmaceutical compositions of 1,3-dioxo-2-(2,6-dioxopiperidin-3-yl)-4-amino isoindoline
Patent 8158653 was granted and assigned to Celgene on April, 2012 by the United States Patent and Trademark Office.
All edits
Edits on 21 Aug, 2024
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Edits on 12 Jan, 2024
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Edits on 28 Nov, 2023
Golden AI
Edits made to:
Article (+214 characters)
Article
Patent abstract
Substituted 2-(2,6-dioxopiperidin-3-yl)phthalimides and 1-oxo-2-(2,6-dioxopiperidin-3-yl)isoindolines are disclosed. The compounds are useful, for example, in reducing the levels of TNFα in a mammal.
Edits on 21 Sep, 2023
Golden AI
Edits made to:
Infobox (+3 properties)
Infobox
Patent Inventor Names
David I. Stirling0
George W. Muller0
Roger Shen-Chu Chen0
Edits on 15 Jul, 2023
Golden AI
Edits made to:
Infobox (+1/-1 properties)
US Patent 08158653 Pharmaceutical compositions of 1,3-dioxo-2-(2,6-dioxopiperidin-3-yl)-4-amino isoindoline US Patent 8158653 Pharmaceutical compositions of 1,3-dioxo-2-(2,6-dioxopiperidin-3-yl)-4-amino isoindoline
Infobox
Patent Number
081586530
Patent Number
81586530
Edits on 24 Apr, 2023
Golden AI
Infobox
Is a
Current Assignee
Patent Jurisdiction
Patent Number
081586530
Date of Patent
April 17, 2012
0Patent Application Number
114018620
Date Filed
April 12, 2006
0Patent Primary Examiner
Edits on 14 Dec, 2021
Golden AI
Edits made to:
Infobox (+8 properties)
US Patent 08158653 Pharmaceutical compositions of 1,3-dioxo-2-(2,6-dioxopiperidin-3-yl)-4-amino isoindoline
Infobox
Is a
Current assignee
Patent jurisdiction
Patent number
08158653
Date of patent
April 17, 2012
Patent application number
11401862
Date Filed
April 12, 2006
Patent primary examiner
Find more entities like US Patent 8158653 Pharmaceutical compositions of 1,3-dioxo-2-(2,6-dioxopiperidin-3-yl)-4-amino isoindoline
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
